Brief Title
The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)
Official Title
The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care
Brief Summary
The study is intended to understand the benefit of Long Term Home care Therapy with nasal High flow in Bronchiectasis patients at home. Primary end point is to evaluate daily life compared to usual care and secondary is to evaluate the changes in lung function
Study Type
Interventional
Primary Outcome
Improvment Daily Life
Secondary Outcome
Evaluation of Arterial Blood Glass
Condition
Bronchiectasis Adult
Intervention
High Flow Humidification
Study Arms / Comparison Groups
Therapy with high flow humidification
Description: The patients will be activated after enrollment with myAirvo2 device at home for 6 months before first observations
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Device
Estimated Enrollment
160
Start Date
September 4, 2019
Completion Date
September 3, 2020
Primary Completion Date
March 3, 2020
Eligibility Criteria
Inclusion Criteria: - Diagnosis of Bronchiectasis on HRCT - Optimization of Therapy for at least 15 days before enrollment - Autonomous patients with possibilities of practicing rehabilitations cycles Exclusion Criteria: - OSAS (ODI>10/h) - HOME NIV - PH<7,35 - paO2< 60mmHg, paCo2> 55 mmHg - Lung cancer - Contraindication to high-flow nasal cannula (hfnc)
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
, +393478482564, [email protected]
Location Countries
Italy
Location Countries
Italy
Administrative Informations
NCT ID
NCT04142827
Organization ID
High Flow in Bronchiectasis
Responsible Party
Sponsor-Investigator
Study Sponsor
Dr. Giuseppe Fiorentino
Study Sponsor
, ,
Verification Date
October 2019